We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.81%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81B
AUM Growth
+$6.66B
(+9%)
Cap. Flow
+$1.82B
Cap. Flow
% of AUM
2.24%
Top 10 Holdings %
Top 10 Hldgs %
22.31%
Holding
3,027
New
17
Increased
2,329
Reduced
595
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$164M |
| 2 |
Microsoft
MSFT
|
+$157M |
| 3 |
Amazon
AMZN
|
+$75.7M |
| 4 |
Tesla
TSLA
|
+$50M |
| 5 |
GE HealthCare
GEHC
|
+$45.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$33M |
| 2 |
STOR
STORE Capital Corporation
STOR
|
+$26.2M |
| 3 |
SIVB
SVB Financial Group
SIVB
|
+$24.9M |
| 4 |
Fair Isaac
FICO
|
+$17M |
| 5 |
LHCG
LHC Group LLC
LHCG
|
+$15.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.37% |
| 2 | Healthcare | 13.58% |
| 3 | Financials | 12.66% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Syndax Pharmaceuticals
SNDX
$1.82B
| $1.92M | ﹤0.01% |
90,854
+10,286
| +13% | +$256K |
|
|
SNCY
1827
DELISTED
Sun Country Airlines
SNCY
| $1.92M | ﹤0.01% |
93,545
+4,764
| +5% | +$92.7K |
|
|
TBI
1828
Trueblue
TBI
$311M
| $1.91M | ﹤0.01% |
107,417
+3,721
| +4% | +$69.6K |
|
1829
Dillards
DDS
$9.56B
| $1.91M | ﹤0.01% |
6,201
+29
| +0.5% | +$10.3K |
|
1830
TriMas Corp
TRS
$1.44B
| $1.9M | ﹤0.01% |
68,303
+1,722
| +3% | +$50.5K |
|
1831
Aurinia Pharmaceuticals
AUPH
$2.11B
| $1.9M | ﹤0.01% |
173,502
+6,949
| +4% | +$61.2K |
|
1832
BioLife Solutions
BLFS
$1.7B
| $1.9M | ﹤0.01% |
87,348
+4,717
| +6% | +$106K |
|
1833
New Fortress Energy
NFE
$101M
| $1.9M | ﹤0.01% |
64,572
+10,689
| +20% | +$377K |
|
1834
Driven Brands
DRVN
$2.2B
| $1.9M | ﹤0.01% |
62,534
+3,020
| +5% | +$85.5K |
|
1835
Kymera Therapeutics
KYMR
$8.94B
| $1.89M | ﹤0.01% |
63,927
+2,707
| +4% | +$87.3K |
|
|
KDNY
1836
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $1.89M | ﹤0.01% |
81,771
+678
| +0.8% | +$16.2K |
|
1837
Mirion Technologies
MIR
$3.91B
| $1.89M | ﹤0.01% |
221,579
+12,044
| +6% | +$95.6K |
|
|
MCW
1838
DELISTED
Mister Car Wash
MCW
| $1.89M | ﹤0.01% |
218,754
+21,153
| +11% | +$198K |
|
|
ATSG
1839
DELISTED
Air Transport Services Group
ATSG
| $1.89M | ﹤0.01% |
90,524
+1,358
| +2% | +$32.8K |
|
|
MFA
1840
MFA Financial
MFA
$933M
| $1.88M | ﹤0.01% |
189,694
+6,379
| +3% | +$67.7K |
|
1841
Q2 Holdings
QTWO
$3.92B
| $1.88M | ﹤0.01% |
76,231
+2,393
| +3% | +$71.2K |
|
1842
Movado Group
MOV
$841M
| $1.88M | ﹤0.01% |
65,204
+1,269
| +2% | +$43K |
|
|
SASR
1843
DELISTED
Sandy Spring Bancorp Inc
SASR
| $1.87M | ﹤0.01% |
72,088
+1,688
| +2% | +$54.3K |
|
|
DO
1844
DELISTED
Diamond Offshore Drilling, Inc.
DO
| $1.87M | ﹤0.01% |
155,293
+5,842
| +4% | +$67.2K |
|
|
GES
1845
DELISTED
Guess Inc
GES
| $1.85M | ﹤0.01% |
95,327
+2,230
| +2% | +$47.8K |
|
1846
Central Pacific Financial
CPF
$1B
| $1.85M | ﹤0.01% |
103,147
+3,358
| +3% | +$71.5K |
|
1847
Clearwater Paper
CLW
$376M
| $1.84M | ﹤0.01% |
55,103
+3,013
| +6% | +$109K |
|
1848
Maravai LifeSciences
MRVI
$919M
| $1.83M | ﹤0.01% |
130,694
+12,463
| +11% | +$179K |
|
1849
Bristow Group
VTOL
$1.36B
| $1.83M | ﹤0.01% |
81,707
+4,202
| +5% | +$112K |
|
1850
Compass Diversified
CODI
$828M
| $1.82M | ﹤0.01% |
95,515
+2,958
| +3% | +$60.5K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2023 Portfolio in Review
As of Q1 2023, RhumbLine Advisers held 3,027 positions worth $81B, up 9% from $74.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 2.6%. RhumbLine Advisers opened 17 new positions and exited 62, leaving the 3,027-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q1 2023 buy was GE HealthCare: 633,417 shares worth $52M.
- RhumbLine Advisers added most to Apple in Q1 2023, an estimated $164M increase.
- RhumbLine Advisers's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $33M.
- RhumbLine Advisers fully exited STORE Capital Corporation in Q1 2023, selling an estimated $26.2M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $81B portfolio in Q1 2023.
- RhumbLine Advisers opened 17 new positions and closed 62 in Q1 2023.
- RhumbLine Advisers's portfolio value rose 9% quarter-over-quarter to $81B.
Based on RhumbLine Advisers's 13F filing for Q1 2023, filed 11 May 2023.